Free Trial

Alpha Teknova (TKNO) Stock Price, News & Analysis

$4.41
+0.01 (+0.23%)
(As of 03:59 PM ET)
Today's Range
$4.15
$4.54
50-Day Range
$1.21
$5.17
52-Week Range
$1.15
$5.45
Volume
71,760 shs
Average Volume
228,664 shs
Market Capitalization
$180.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00

Alpha Teknova MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
14.2% Upside
$5.00 Price Target
Short Interest
Healthy
2.55% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.58mentions of Alpha Teknova in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$15.15 M Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.54) to ($0.36) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.28 out of 5 stars

Medical Sector

539th out of 927 stocks

Diagnostic Substances Industry

6th out of 14 stocks

TKNO stock logo

About Alpha Teknova Stock (NASDAQ:TKNO)

Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

TKNO Stock Price History

TKNO Stock News Headlines

Introducing the Perceptron
On Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016.
Alpha Teknova Inc (TKNO)
Teknova Reports Second Quarter 2024 Financial Results
Introducing the Perceptron
On Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016.
What Wall Street expects from Alpha Teknova's earnings
Teknova Announces $15.4 Million Private Placement
See More Headlines
Receive TKNO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alpha Teknova and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/13/2024
Today
9/16/2024
Next Earnings (Estimated)
11/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostic substances
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TKNO
Fax
N/A
Employees
240
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.00
High Stock Price Target
$5.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+17.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-36,780,000.00
Pretax Margin
-99.05%

Debt

Sales & Book Value

Annual Sales
$34.94 million
Book Value
$2.21 per share

Miscellaneous

Free Float
34,618,000
Market Cap
$173.09 million
Optionable
Not Optionable
Beta
0.43
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

TKNO Stock Analysis - Frequently Asked Questions

How have TKNO shares performed this year?

Alpha Teknova's stock was trading at $3.73 at the start of the year. Since then, TKNO stock has increased by 17.4% and is now trading at $4.38.
View the best growth stocks for 2024 here
.

How were Alpha Teknova's earnings last quarter?

Alpha Teknova, Inc. (NASDAQ:TKNO) released its quarterly earnings results on Tuesday, August, 13th. The company reported ($0.13) earnings per share for the quarter, beating analysts' consensus estimates of ($0.16) by $0.03. The firm earned $9.61 million during the quarter, compared to analyst estimates of $9.50 million. Alpha Teknova had a negative trailing twelve-month return on equity of 37.00% and a negative net margin of 98.08%.

When did Alpha Teknova IPO?

Alpha Teknova (TKNO) raised $90 million in an IPO on Friday, June 25th 2021. The company issued 6,000,000 shares at a price of $14.00-$16.00 per share.

Who are Alpha Teknova's major shareholders?

Alpha Teknova's top institutional investors include Conestoga Capital Advisors LLC (1.11%) and Dimensional Fund Advisors LP (0.05%). Insiders that own company stock include Telegraph Hill Partners Iv, L, Ted Davis, J Matthew Mackowski, Stephen Gunstream, Matthew Lowell, Damon Terrill, Lisa Hood and Ken Gelhaus.
View institutional ownership trends
.

How do I buy shares of Alpha Teknova?

Shares of TKNO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TKNO) was last updated on 9/16/2024 by MarketBeat.com Staff

From Our Partners